Yousif Capital Management LLC Has $13.08 Million Stock Holdings in Cardinal Health, Inc. (NYSE:CAH)

Yousif Capital Management LLC lowered its stake in Cardinal Health, Inc. (NYSE:CAH) by 4.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 110,599 shares of the company’s stock after selling 4,879 shares during the period. Yousif Capital Management LLC’s holdings in Cardinal Health were worth $13,081,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of CAH. Avitas Wealth Management LLC acquired a new stake in shares of Cardinal Health during the 4th quarter valued at $1,466,000. E. Ohman J or Asset Management AB raised its position in Cardinal Health by 15.0% in the fourth quarter. E. Ohman J or Asset Management AB now owns 11,500 shares of the company’s stock valued at $1,360,000 after purchasing an additional 1,500 shares during the last quarter. Patron Partners LLC boosted its stake in shares of Cardinal Health by 6.1% during the fourth quarter. Patron Partners LLC now owns 2,043 shares of the company’s stock valued at $242,000 after purchasing an additional 117 shares in the last quarter. Columbus Macro LLC grew its holdings in shares of Cardinal Health by 55.1% during the fourth quarter. Columbus Macro LLC now owns 18,319 shares of the company’s stock worth $2,167,000 after purchasing an additional 6,510 shares during the last quarter. Finally, Resonant Capital Advisors LLC increased its stake in shares of Cardinal Health by 1.9% in the fourth quarter. Resonant Capital Advisors LLC now owns 8,698 shares of the company’s stock valued at $1,029,000 after buying an additional 160 shares during the period. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Performance

CAH stock opened at $125.29 on Wednesday. The stock’s 50 day simple moving average is $122.16 and its 200 day simple moving average is $114.75. The company has a market cap of $30.27 billion, a P/E ratio of 23.38, a price-to-earnings-growth ratio of 1.46 and a beta of 0.63. Cardinal Health, Inc. has a fifty-two week low of $93.17 and a fifty-two week high of $132.84.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. Equities analysts predict that Cardinal Health, Inc. will post 7.92 earnings per share for the current year.

Cardinal Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be issued a $0.5056 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.61%. Cardinal Health’s dividend payout ratio is presently 37.69%.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on CAH. Mizuho started coverage on shares of Cardinal Health in a report on Wednesday, December 4th. They set an “outperform” rating and a $139.00 target price on the stock. Wells Fargo & Company boosted their price objective on shares of Cardinal Health from $135.00 to $136.00 and gave the stock an “equal weight” rating in a research note on Tuesday. StockNews.com lowered Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Sunday, November 3rd. Morgan Stanley upped their price target on Cardinal Health from $136.00 to $142.00 and gave the company an “overweight” rating in a research report on Friday, January 31st. Finally, UBS Group raised their price objective on Cardinal Health from $134.00 to $139.00 and gave the stock a “buy” rating in a research report on Monday, November 4th. Four research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $135.93.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.